New guidelines on prostate cancer screenings highlight important symptoms to watch for.
Prostate cancer is increasingly recognized as a significant health concern, with one in eight men receiving a diagnosis during their lifetime. Despite it being the second leading cause of cancer death among men in the U.S., the majority of those diagnosed will not succumb to the illness. With the latest guidance from the American Cancer Society, screening recommendations for prostate cancer have shifted to emphasize the importance of early detection.
Updated Screening Guidelines
On November 12, the American Cancer Society unveiled its new screening guidelines, marking the first substantial update in over 16 years. Men between the ages of 50 and 69 with an average risk of prostate cancer are now advised to undergo screening every two years. For those at an elevated risk, which includes Black men and individuals with a strong family history of the disease, annual screenings are recommended starting at age 45. Dr. Akshay Syal, an NBC News medical contributor, describes this change as a “significant shift” in the approach to prostate health, emphasizing the importance of timely screenings.
This update comes as Black men face a 67% higher incidence rate and nearly double the mortality rate from prostate cancer when compared to their white counterparts. Dr. William Dahut, chief scientific officer at the American Cancer Society, highlights this disparity as an urgent issue needing attention.
Understanding Prostate Specific Antigen (PSA) Testing
Screening for prostate cancer typically begins with a blood test that checks the levels of prostate-specific antigen (PSA). Elevated levels of PSA may signal the presence of a tumor, prompting further investigations such as MRIs and potential biopsies. Dr. Robert Smith, from the American Cancer Society, reinforces the significance of PSA testing, stating, “PSA testing remains the cornerstone of detecting prostate cancer early, and we now have stronger evidence of its benefits.”
The guidelines suggest that men aged 70 to 74 should consult with their doctors to assess if screenings are appropriate for them, while routine screenings are not recommended for men aged 75 and older.
Common Symptoms to Recognize
As a medical oncologist at the Mayo Clinic, Dr. Dan Childs takes a keen interest in diagnosing prostate cancer. He is acutely aware of the disease's prevalence and urges men to prioritize understanding its potential warning signs. According to Dr. Childs, many men remain unaware that prostate cancer is often asymptomatic in its early stages. Below are key symptoms that he emphasizes:
- Changes in Urination: A weak urinary stream, difficulty initiating urination, or increased nighttime bathroom trips can indicate issues with the prostate, often linked to its enlargement.
- Blood in Urine: Noticing blood in urine should prompt immediate medical attention, as it could indicate a serious underlying condition.
- Bone Pain: An unexplained, persistent pain in the back, hips, or pelvis could mean that cancer has spread to the bones.
- Unexplained Weight Loss: Sudden weight loss or persistent fatigue may signal advanced cancer. Dr. Childs suggests that these symptoms should always be taken seriously.
The Importance of Proactive Screening
Early detection is crucial, especially as the risk of developing prostate cancer increases significantly after the age of 50. By age 70, nearly half of men may show signs of cancer cells in their prostate. The disease, often referred to as a